Biomarin Pharmaceutical Inc

Biomarin Pharmaceutical Inc

  • Price (USD)93.54
  • Today's Change-1.12 / -1.18%
  • Shares traded1.10m
  • 1 Year change9.47%
  • Beta1.8038
Data delayed at least 15 minutes, as of Oct 17 2017 21:00 BST.
More ▼

Events & Activity

  • BMRN:NSQ price moved over -1.46% to 93.74
  • BMRN:NSQ price falls below 15-day moving average to 94.01 at 10:30 BST
  • BMRN:NSQ price falls below 15-day moving average to 93.74 at 11:58 BST

Key statistics

On Tuesday, Biomarin Pharmaceutical Inc (BMRN:NSQ) closed at 93.54, -6.93% below its 52-week high of 100.51, set on May 05, 2017.
52-week range
78.42Nov 03 2016100.51May 05 2017
Markit short selling activity
Previous close94.66
Average volume925.57k
Shares outstanding175.27m
Free float174.61m
P/E (TTM)--
Market cap16.59bn USD
EPS (TTM)-1.02
Data delayed at least 15 minutes, as of Oct 17 2017 21:00 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.